Going Concern (new) — Company disclosed substantial doubt about ability to continue as going concern due to increased R&D costs from three new Phase 2 trials exceeding available cash within 12 months.

NASDAQ: VSTM Verastem, Inc. 10-Q

Verastem launches three Phase 2 trials, discloses going concern as cash runway tightens

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade VSTM commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 1:16 AM